T
TG Therapeutics
TG Therapeutics - A Biopharmaceutical Company
About TG Therapeutics
TG Therapeutics is a commercial-stage biopharmaceutical company that acquires, develops, and commercializes treatments for B-cell malignancies and autoimmune diseases. The company's primary focus is on leveraging scientific advances in B-cell biology to develop novel treatments for patients. Its main product is BRIUMVI®, a treatment for relapsing forms of multiple sclerosis (RMS).
TG Therapeutics has a global license agreement with Precision BioSciences for the development and commercialization of Precision's allogeneic CD19 CAR T cell therapy program. The company's business model is focused on the acquisition, development, and commercialization of pharmaceutical products. TG Therapeutics generates revenue through the sale of its approved products.
Source: Dealroom company dataAt a glance
- Status
- Listed
- Founded
- 2011
- Headquarters
- Morrisville, United States
- Listing
- IPO 2003
- Sector
- Biotech & Life Sciences
- Outcome tier
- Unicorn$1–10B valuation tierThoroughbred$100M+ revenue
News
Open roles
TG Therapeutics in the Morrisville ecosystem
The TG Therapeutics office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series B and later4 investors entered at this stage
Hercules Capital
Blue Owl Capital
HealthCare Royalty
ACT Capital Management
Source: Dealroom Talent Intelligence.
Global footprint
team presence
across markets
Patents
5 active patent families included in this estimate.
A patent family groups patent filings for the same invention. Source: Dealroom · PatSnap.
Market sentiment
An AI-synthesised read of the highest-engagement posts about TG Therapeutics on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See TG Therapeutics on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.
